Posted on 08/29/2023 9:12:39 PM PDT by algore
US President Biden has introduced a proactive strategy aimed at securing additional funding from Congress to support the development of a groundbreaking COVID-19 vaccine.
Here’s President Joe Biden's bold plan for mandatory immunization
Amidst the ongoing battle against the COVID-19 pandemic, US President Biden has unveiled a proactive strategy, intending to seek additional funding from Congress for the development of a novel COVID-19 vaccine. Furthermore, he suggested the possibility of mandating this new vaccine for all individuals, regardless of their prior vaccination status.
President Biden made a significant announcement on Friday regarding the nation's ongoing fight against the virus. Responding to a reporter's inquiry about the surge in COVID-19 cases and the emergence of a new variant, the president was forthcoming with his plans.
"Yes, I can," President Biden affirmed. "I signed off this morning on a proposal we have to present to Congress—a request for additional funding for a new vaccine that is necessary, that works."
Pioneering the Next Phase: Universal Vaccination:
President Biden went on to indicate a groundbreaking approach to vaccination strategy. He revealed that tentative recommendations point toward the likelihood of a universal vaccination mandate, encompassing all individuals, irrespective of whether they have previously received a COVID-19 vaccine.
Intricacies of Funding and Legislative Support While the President's vision holds promise, the financial aspect remains crucial.
A previous funding request to Congress on August 11, amounting to $40 million, excluded references to coronavirus-related expenses.
Instead, it encompassed funding allocations for matters such as the Ukraine crisis, U.S. federal disaster funds, and fortifications along the U.S.-Mexico border to counteract the influx of fentanyl
Reflecting on past funding requests, the Biden administration had sought $9.25 billion in 2022 to combat the virus. However, congressional lawmakers rejected this appeal, showcasing the challenges of achieving the necessary financial backing for public health initiatives.
The Associated Press reported that health officials are anticipating the rollout of an updated COVID-19 vaccine targeting a specific variant—XBB.1.5 of the omicron strain. This novel vaccine signifies a departure from current combination shots, which blend the original coronavirus strain with prevalent omicron variants from the previous year.
Given the persistent mutation of the coronavirus, the need for vaccine adaptation remains a constant. As we approach the following month, citizens can anticipate the introduction of the annual fall COVID-19 shot.
Renowned pharmaceutical companies Pfizer, Moderna, and Novavax are diligently working to formulate doses of the XBB update.
Navigating the Path Forward While these developments hold promise, the regulatory pathway is essential. The Food and Drug Administration (FDA) will play a crucial role in evaluating and approving each vaccine, ensuring safety and efficacy. Subsequently, the U.S. Centers for Disease Control and Prevention (CDC) will provide recommendations regarding the utilization of the vaccines.
As the new booster program looms on the horizon, it marks nearly a year since President Biden's declaration of the COVID-19 pandemic as "over" in September 2022.
“… Amidst the ongoing battle against the COVID-19 pandemic…”
****************************************************************
Battle? Pandemic? Sorry Joe & friends, nobody believes ANYTHING you say now.
Very few people will play the game this time. This will cause them to take more drastic police state measures.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.